Blood test aims to Fine-Tune Anti-Rejection drugs for kidney transplants
Disease control
Terminated
This study looked at whether a special blood test called ImmuKnow could help doctors better manage immunosuppressant drugs in new kidney transplant patients. The goal was to reduce infections and prevent organ rejection. Only 4 people took part before the study was stopped early.
Phase: PHASE4 • Sponsor: CAMC Health System • Aim: Disease control
Last updated May 07, 2026 18:41 UTC